Aller au contenu principal
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
FR
FR
EN
PT
NL
NB
Company press releases
Subscribe
Filtres
Filtres
Actualiser
Réinitialiser
Icon After
Date
Toggle Visibility
Tout
Aujourd'hui
Cette semaine
This month
Custom date range
From
To
Topic
Toggle Visibility
Annual financial and audit Reports
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
Datapresse
EQS Group
Euronext
Les Echos
Marketwire
Oslo Børs Newspoint
PR Newswire
Thomson Reuters ONE
Displaying 1 - 21 of 21 results
Released
Company
Title
Industry
Topic
21 Jan 2021
15:30 CET
MITHRA
Mithra announces placement of EUR 125 million convertible bonds due 2025
20103015 Pharmaceuticals
Other financial transaction
21 Jan 2021
15:26 CET
MITHRA
First Half 2020 financial report
20103015 Pharmaceuticals
Corporate life
18 Jun 2020
20:45 CEST
MITHRA
Mithra Successfully Raises EUR 65.0 Million By Means of a Private Placement via an Accelerated Bookbuild Offering
20103015 Pharmaceuticals
Change in Capital
18 Jun 2020
14:39 CEST
MITHRA
Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy
20103015 Pharmaceuticals
Change in Capital
09 Mar 2020
07:30 CET
MITHRA
Mithra annonce ses résultats annuels 2019
Pharmaceuticals
Corporate life
09 Mar 2020
07:30 CET
MITHRA
Mithra Reports Full Year 2019 Financial Results
Pharmaceuticals
Corporate life
10 Jan 2020
10:00 CET
MITHRA
E4 Paves the Road Towards a Revolutionary Era of Environmental Friendly Medicines
Pharmaceuticals
Trends / Analyses
01 Oct 2019
13:13 CEST
MITHRA
MITHRA SUCESSFULLY RENEGOTIATES EARNOUT PAYMENTS
Pharmaceuticals
Alliances and agreements
01 Oct 2019
13:12 CEST
MITHRA
MITHRA SIGNS LANDMARK CONTRACT FOR ESTELLE® IN THE UNITED STATES WITH MAYNE PHARMA
Pharmaceuticals
Alliances and agreements
19 Sep 2019
11:17 CEST
MITHRA
First half 2019 financial report
Pharmaceuticals
Corporate life
19 Sep 2019
07:49 CEST
MITHRA
Mithra Announces 2019 Half Year Results
Pharmaceuticals
Corporate life
08 Apr 2019
11:19 CEST
MITHRA
Mithra Releases 2018 Annual Report and Invitation to its General Shareholders’ Meeting
Pharmaceuticals
Corporate life
01 Mar 2019
08:43 CET
MITHRA
Mithra Reports 2018 Annual Results
Pharmaceuticals
Corporate life
30 Jan 2019
11:27 CET
MITHRA
Mithra annonce les premiers résultats positifs pour l’étude de phase III du contraceptif oral Estelle® aux États-Unis/Canada
Pharmaceuticals
-
22 Jan 2019
18:00 CET
MITHRA
MITHRA REPORTS 2017 ANNUAL RESULTS
Pharmaceuticals
Corporate life
22 Jan 2019
14:59 CET
MITHRA
Blockbuster potentiel en périménopause avec un nouveau produit candidat à base d’E4 et accélération du programme de Phase III pour Donesta
Pharmaceuticals
-
22 Jan 2019
14:55 CET
MITHRA
MITHRA ANNONCE SES RÉSULTATS SEMESTRIELS 2018
Pharmaceuticals
-
21 Sep 2017
07:30 CEST
MITHRA
Mithra publie ses résultats semestriels 2017
Pharmaceuticals
-
21 Sep 2017
07:30 CEST
MITHRA
Mithra announces 2017 half year results
Pharmaceuticals
-
28 Jun 2017
07:30 CEST
MITHRA
Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and ASEAN
Pharmaceuticals
-
28 Jun 2017
07:30 CEST
MITHRA
Mithra signe un accord de licence et d’approvisionnement exclusif avec Fuji Pharma pour Donesta® au Japon et en ASEAN
Pharmaceuticals
-
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Accueil
+ MARCHÉS
+ MARCHÉS
Amsterdam
Amsterdam
Cash Products
Cash Products
Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Company regulated news
Euronext Bruxelles
Euronext Bruxelles
Marchés au comptant
Marchés au comptant
Actions
Indices
Obligations
ETFs
Produits structurés
Marchés dérivés
Marchés dérivés
Dérivés sur Indices
Options sur Actions
Futures sur Actions
Dérivés sur Dividendes
Company regulated news
Expert Market
Euronext Dublin
Euronext Dublin
DOL
Euronext Lisbonne
Euronext Lisbonne
Cash Products
Cash Products
Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Derivative products
Index futures
Stock futures
Dividend derivatives
Company regulated news
Oslo
Oslo
Cash Products
Cash Products
Stocks
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
Equity indices
Bonds
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Company regulated news
Financial calendars
Primary insiders
Paris
Paris
Marchés au comptant
Marchés au comptant
Actions
Indices
Obligations
ETFs
Produits structurés
Fonds
Marchés dérivés
Marchés dérivés
Futures sur Indices
Options sur Indices
Options sur Actions
Futures sur Actions
Dérivés sur Dividendes
Communiqués sociétés
Actions
Actions
Company regulated news
IPOs
IPOs
All IPOs
Listing sponsors
Morningstar reports
Morningstar reports
Family business
Tech companies
European Rising Tech Label
Indices
Indices
Indices factsheets
Indices rules
Indices benchmark statements
Index consultations
Market data news
ESG indices
Contact Euronext indices
ETFs
ETFs
ESG ETFs
Fonds
Obligations
Obligations
ESG Bonds
Produits Structurés
Dérivés actions & devises
Dérivés actions & devises
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Marchandises
Marchandises
Quotes snapshot
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Ressources
Ressources
Statistics & reports
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Quote vendor codes
Stock options
Stock Futures
Dividend Futures
Index Options
Index Futures
Commodities
Key Information Document
Key Information Document
Class level
Product group level
Notices / Corporate actions
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Market events
Halted instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Members list
Issuers compliance
Où trouver ?